Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MNP-VERU
- Development stage
- Preclinical
- Lead developer
- University of Tennessee
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
MNP-VERU is a nanoparticle formulation of the tubulin inhibitor VERU-111 (sabizabulin). It consists of magnetic nanoparticles (MNPs) loaded with VERU-111, designed to enhance the delivery, bioavailability, and therapeutic index of the drug in the treatment of pancreatic cancer. The formulation targets beta-III and beta-IV tubulin isoforms, which are often overexpressed in drug-resistant tumors. By inhibiting these tubulin subunits and modulating miR-200c expression, MNP-VERU disrupts microtubule assembly, leading to cell cycle arrest and apoptosis. Preclinical studies have demonstrated that MNP-VERU is more effective than the free drug in suppressing pancreatic cancer cell growth and reducing tumor volume in xenograft models.
- Other names
- nanoparticle formulation of VERU-111MNP-VERU-111MNP-VERU111MNP-VERU 111
Beyond the preview
Go deeper on MNP-VERU.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MNP-VERU.